Details
Imunovir-Zdorovye Indications
The drug is indicated for the treatment of reduced or dysfunctional cellular immunity and for the treatment of clinical symptoms in the following diseases:
Primary and secondary viral respiratory infections.
Viral infections caused by herpes simplex virus types 1 and 2, chickenpox virus (VZV), cytomegalovirus (CMV) or Epstein-Barr virus (EBV).
Genital warts (condyloma acuminata) - external lesions (except for meatal and perianal localization) as monotherapy or as an adjunct to conventional local or surgical treatment.
Mucosal infections, subclinical vulvovaginal infections, or HPV (human papillomavirus) infections are associated with the endocervix.
Viral hepatitis.
Measles with a complex course or with complications.
Subacute sclerosing panencephalitis (SSPE).
Contraindications
The drug should not be used:
· Patients who have a hypersensitivity to the active substance or to any of the excipients of the drug;
· Patients during an acute attack of gout;
· Patients with elevated levels of uric acid in the blood (hyperuricemia).
Dosage & Administration
This medicine is for oral use only.
The daily dose should be divided evenly over the course of the day.
Dosage.
The dosage is determined individually, depending on the patient's body weight and the course of the disease.
Adults, including elderly patients.
The recommended daily dose is 50 mg / kg body weight per day (ie 1 ml / kg), usually 3 g (or 60 ml) of syrup, divided into 3-4 doses per day. The maximum daily dose is 4 g
Children.
The recommended daily dose is 50 mg / kg body weight (1 ml / kg) per day, evenly distributed in 3-4 doses per day
Also called Immunovir, Имуновир